5-(Methylsulfanyl)pentanenitrile
| Common Name: |
5-(Methylsulfanyl)pentanenitrile |
| IUPAC Name: |
5-methylsulfanylpentanenitrile |
| Molecular Formula: |
C6H11NS |
| SMILES: |
CSCCCCC#N |
| Inchi: |
1S/C6H11NS/c1-8-6-4-2-3-5-7/h2-4,6H2,1H3 |
| Inchi Key: |
XPUDGEZWSNPCMM-UHFFFAOYSA-N |
| Cas No: |
59121-25-4 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
3 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
129.22 |
| Mass (g/mol) |
129.061 |
| Molar Refractivity |
38.30 |
| Net Charge |
|
| HBD |
|
| HBA |
1 |
| Rt Bonds |
4 |
| Rings |
|
| TPSA |
49.09 |
| Hetero Atoms |
2 |
| Heavy Atoms |
8 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
241.00 to 242.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.037 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.83 |
| LogP |
2.043 |
| iLOGP |
1.76 |
| XLOGP3 |
1.28 |
| WLOGP |
2.04 |
| MLOGP |
1.39 |
| ESOL Log S |
-1.18 |
| ESOL Solubility (mg/ml) |
8.47 |
| ESOL Solubility (mol/l) |
0.066 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-1.91 |
| Ali Solubility (mg/ml) |
1.59 |
| Ali Solubility (mol/l) |
0.01 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-2.04 |
| Silicos-IT Solubility (mg/ml) |
1.17 |
| Silicos-IT Solubility (mol/l) |
0.01 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.18 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.744 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
2.732 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
